Propagenix Inc.

BiotechnologyMaryland, United States2-10 Employees

Propagenix Inc. operates in the biotechnology research sector, focusing on developing and commercializing products that enable basic and translational biomedical research. The company aims to support the discovery and development of drugs, personalized diagnostics, and cell therapies by creating physiologically relevant in vitro tissue models that replicate functions of normal and diseased organs without relying on animal models. Its work centers on epithelial stem cell culture and differentiation to model barrier epithelia of the airway, kidney, and gastrointestinal tissues, providing tools for studying respiratory pathogens, assessing drug and toxicant effects on epithelial health, and exploring tumor models and cell therapies for airway and epidermal diseases.
Based in Gaithersburg, Maryland, Propagenix targets biopharma companies, contract research organizations, and consumer product firms involved in epithelial cell biology research and development. The company invites collaboration with scientists interested in improving epithelial tissue models and explores research partnerships that may lead to new product designs, as well as beta testing opportunities for its tissue models. A recent development highlighted is a partnership with STEMCELL Technologies to commercialize Propagenix’s EpiX technology for expanding tissue-resident epithelial stem cells, reflecting its position within the life sciences tools ecosystem.

Sign up for free to view info

Email Format Employee directory